Works matching IS 15228517 AND DT 2017 AND VI 19 AND IP 12
Results: 28
Transition: Message from the Editor-in-Chief.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1567, doi. 10.1093/neuonc/nox201
- By:
- Publication type:
- Article
Et tu, ibrutinib? A promising stab at CNS lymphoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1575, doi. 10.1093/neuonc/nox200
- Publication type:
- Article
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1574, doi. 10.1093/neuonc/nox200
- Publication type:
- Article
Diffusion MRI phenotypes predict overall survival benefit from anti-VEGF monotherapy in recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1573, doi. 10.1093/neuonc/nox200
- Publication type:
- Article
The whole-genome landscape of medulloblastoma subtypes.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1573, doi. 10.1093/neuonc/nox200
- Publication type:
- Article
ASCL1 reorganizes chromatin to direct neuronal fate and suppress tumorigenicity of glioblastoma stem cells.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1572, doi. 10.1093/neuonc/nox200
- Publication type:
- Article
Transcription factors critical for tumor growth in vivo may not be detected in conventional in vitro screens.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1572, doi. 10.1093/neuonc/nox200
- Publication type:
- Article
Society News.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1700, doi. 10.1093/neuonc/nox199
- Publication type:
- Article
Corrigenda.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1703, doi. 10.1093/neuonc/nox190
- Publication type:
- Article
The endothelial prostatespecific membrane antigen is highly expressed in gliosarcoma and visualized by [<sup>68</sup>Ga]-PSMA-11 PET: a theranostic outlook for brain tumor patients?
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1698, doi. 10.1093/neuonc/nox172
- By:
- Publication type:
- Article
IDH mutation testing in gliomas--where do we draw the line?
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1568, doi. 10.1093/neuonc/nox164
- By:
- Publication type:
- Article
Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1673, doi. 10.1093/neuonc/nox135
- By:
- Publication type:
- Article
Putting "multiforme" back into glioblastoma: intratumoral transcriptome heterogeneity is a consequence of its complex morphology.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1570, doi. 10.1093/neuonc/nox131
- By:
- Publication type:
- Article
A description of familial clustering of meningiomas in the Utah population.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1683, doi. 10.1093/neuonc/nox127
- By:
- Publication type:
- Article
Outcome of patients with intracranial nongerminomatous germ cell tumors--lessons from the SIOP-CNS-GCT-96 trial.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1661, doi. 10.1093/neuonc/nox122
- By:
- Publication type:
- Article
Cost-effectiveness of radiation and chemotherapy for high-risk low-grade glioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1651, doi. 10.1093/neuonc/nox121
- By:
- Publication type:
- Article
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1640, doi. 10.1093/neuonc/nox120
- By:
- Publication type:
- Article
PET imaging in patients with meningioma--report of the RANO/PET Group.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1576, doi. 10.1093/neuonc/nox112
- By:
- Publication type:
- Article
Corrigenda.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1701, doi. 10.1093/neuonc/nox110
- Publication type:
- Article
Corrigenda.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1702, doi. 10.1093/neuonc/nox108
- Publication type:
- Article
Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1628, doi. 10.1093/neuonc/nox104
- By:
- Publication type:
- Article
Corrigenda.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1701, doi. 10.1093/neuonc/nox102
- Publication type:
- Article
Diagnostic challenges in meningioma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1588, doi. 10.1093/neuonc/nox101
- By:
- Publication type:
- Article
Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1599, doi. 10.1093/neuonc/nox100
- By:
- Publication type:
- Article
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1607, doi. 10.1093/neuonc/nox093
- By:
- Publication type:
- Article
Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1688, doi. 10.1093/neuonc/nox092
- By:
- Publication type:
- Article
Corrigenda.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1701, doi. 10.1093/neuonc/nox088
- Publication type:
- Article
Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1618, doi. 10.1093/neuonc/nox097
- By:
- Publication type:
- Article